Impact on the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus

被引：0
|
作者：
Reina, Jordi [1 ]
Viana-Ramirez, Julia [1 ]
机构：
[1] Hosp Univ Son Espases, Serv Microbiol, Unidad Virol, Carretera Valldemossa 79, Palma De Mallorca 07120, Spain
来源：
REVISTA ESPANOLA DE QUIMIOTERAPIA | 2024年 / 37卷 / 06期
关键词：
INFECTIONS;
D O I：
10.37201/req/049.2024
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：96
相关论文
共 50 条
  • [1] Nirsevimab Immunization to Prevent Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants and Children up to 24 Months of Age
    Cieslak, Chelsea M.
    NURSING FOR WOMENS HEALTH, 2024, 28 (01) : 75 - 79
  • [2] Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus
    Xu, Hanmeng
    Aparicio, Camila
    Wats, Aanchal
    Araujo, Barbara L.
    Pitzer, Virginia E.
    Warren, Joshua L.
    Shapiro, Eugene D.
    Niccolai, Linda M.
    Weinberger, Daniel M.
    Oliveira, Carlos R.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [3] Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy
    Marcellusi, Andrea
    Bini, Chiara
    Muzii, Barbara
    Soudani, Samira
    Kieffer, Alexia
    Beuvelet, Matthieu
    Bozzola, Elena
    Midulla, Fabio
    Baraldi, Eugenio
    Bonanni, Paolo
    Boccalini, Sara
    Orfeo, Luigi
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2025, 12 : 16 - 28
  • [4] Nirsevimab effectiveness against hospital admission for respiratory syncytial virus bronchiolitis in infants
    Rodriguez-Fernandez, Rosa
    Gonzalez-Martinez, Felipe
    Velazquez, Ines Ojeda
    Diaz, Marta Rodriguez
    Bucciol, Maria Victoria Capozzi
    Gonzalez-Sanchez, Maria Isabel
    Perez-Moreno, Jimena
    del Castillo, Blanca Toledo
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2024, 37 (06)
  • [5] PUBLIC HEALTH IMPACT OF NIRSEVIMAB AGAINST LOWER RESPIRATORY INFECTIONS ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS AMONG CHINESE INFANTS
    Lai, X.
    Ma, Y.
    Zou, W.
    Soudani, S.
    Fang, H.
    VALUE IN HEALTH, 2023, 26 (12) : S241 - S241
  • [6] Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024
    Razzaghi, Hilda
    Garacci, Emma
    Kahn, Katherine E.
    Lindley, Megan C.
    Jones, Jefferson M.
    Stokley, Shannon
    Calhoun, Kayla
    Black, Carla L.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2024, 73 (38): : 837 - 843
  • [7] Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain
    Moreno, Matilde Zornoza
    Martin, Jaime Jesus Perez
    Moreno, M. Cruz Gomez
    Abellan, M. Pilar Ros
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [8] Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting
    Lopez-Lacort, Monica
    Munoz-Quiles, Cintia
    Mira-Iglesias, Ainara
    Xavier Lopez-Labrador, F.
    Garces-Sanchez, Maria
    Escribano-Lopez, Begona
    Zornoza-Moreno, Matilde
    Jesus Perez-Martin, Jaime
    Alfayate-Miguelez, Santiago
    Arce, Antonio Iofrio-De
    Pastor-Villalba, Eliseo
    Antonio Lluch-Rodrigo, Jose
    Diez-Domingo, Javier
    Orrico-Sanchez, Alejandro
    MEDIPRIM Network
    PEDIATRICS, 2025, 155 (01)
  • [9] Current concepts on active immunization against respiratory syncytial virus for infants and young children
    Kneyber, MCJ
    Kimpen, JLL
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (07) : 685 - 696
  • [10] Effectiveness of nirsevimab introduction against respiratory syncytial virus in the Valencian Community: A preliminary assessment
    Estrella-Porter, Pablo
    Blanco-Calvo, Carolina
    Lameiras-Azevedo, Ana Sofia
    Juaneda, Juan
    Fernandez-Martinez, Sergio
    Gomez-Pajares, Fernandp
    Tempelsman, Rocio
    Roig-Sena, Francisco Javier
    Perez-Panades, Jordi
    Botella-Rocamora, Paloma
    Lluch-Rodrigo, Jose Antonio
    Pastor-Villalba, Eliseo
    VACCINE, 2024, 42 (22)
12345